DK3215173T3 - Glycopeptidsammensætninger - Google Patents

Glycopeptidsammensætninger Download PDF

Info

Publication number: DK3215173T3
Authority: DK; Denmark
Prior art keywords: glycopeptime; compositions; glycopeptime compositions
Prior art date: 2014-11-06

Application number

DK15791287.4T

Other languages

English (en)

Inventor

Katarina Pindric

Ivona Jasprica

Sabina Keser

Original Assignee

Xellia Pharmaceuticals Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-11-06

Filing date

2015-11-06

Publication date

2020-03-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54478023&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3215173(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-11-06 Application filed by Xellia Pharmaceuticals Aps filed Critical Xellia Pharmaceuticals Aps

2020-03-23 Application granted granted Critical

2020-03-23 Publication of DK3215173T3 publication Critical patent/DK3215173T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

DK15791287.4T 2014-11-06 2015-11-06 Glycopeptidsammensætninger DK3215173T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201462076400P	2014-11-06	2014-11-06
US201562168749P	2015-05-30	2015-05-30
PCT/EP2015/075918 WO2016071495A1 (en)	2014-11-06	2015-11-06	Glycopeptide compositions

Publications (1)

Publication Number	Publication Date
DK3215173T3 true DK3215173T3 (da)	2020-03-23

Family

ID=54478023

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK19174849.0T DK3542812T3 (da)	2014-11-06	2015-11-06	Glycopeptidsammensætninger
DK15791287.4T DK3215173T3 (da)	2014-11-06	2015-11-06	Glycopeptidsammensætninger

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK19174849.0T DK3542812T3 (da)	2014-11-06	2015-11-06	Glycopeptidsammensætninger

Country Status (30)

Country	Link
US (7)	US10188697B2 (da)
EP (4)	EP3834837A1 (da)
JP (2)	JP6797795B2 (da)
KR (2)	KR102763211B1 (da)
CN (1)	CN107073072B (da)
AU (1)	AU2015341763B2 (da)
BR (1)	BR112017009405B1 (da)
CA (1)	CA2964524A1 (da)
CL (1)	CL2017001139A1 (da)
CO (1)	CO2017005391A2 (da)
CR (1)	CR20170234A (da)
CY (2)	CY1122960T1 (da)
DK (2)	DK3542812T3 (da)
EA (1)	EA035368B1 (da)
ES (2)	ES2769849T3 (da)
HR (2)	HRP20200101T1 (da)
HU (2)	HUE049857T2 (da)
IL (1)	IL252120B (da)
MX (1)	MX2017005749A (da)
NZ (1)	NZ731955A (da)
PH (1)	PH12017500720A1 (da)
PL (2)	PL3542812T3 (da)
PT (2)	PT3542812T (da)
RS (2)	RS59851B1 (da)
SA (1)	SA517381446B1 (da)
SG (1)	SG11201703568WA (da)
SI (2)	SI3542812T1 (da)
TN (1)	TN2017000182A1 (da)
WO (1)	WO2016071495A1 (da)
ZA (1)	ZA201702767B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102763211B1 (ko)	2014-11-06	2025-02-04	셀리아 파마슈티칼즈 에이피에스	글리코펩티드 조성물
EP3393491A1 (en) *	2015-12-24	2018-10-31	Universiteit Leiden	Composition and method for treating infections caused by vancomycin-resistant infectious agents in a subject
MX2018013584A (es) *	2016-05-09	2019-04-01	Xellia Pharmaceuticals Aps	Formulaciones de antibioticos glicopeptidicos estabilizados.
WO2018096556A1 (en) *	2016-11-23	2018-05-31	Gufic Biosciences Limited	Lyophilized pharmaceutical compositions of dalbavancin
JP7118412B2 (ja) *	2017-07-31	2022-08-16	東洋製薬化成株式会社	バンコマイシン懸濁液充填カプセル製剤
CN109725101B (zh) *	2017-10-31	2021-11-19	正大天晴药业集团股份有限公司	盐酸特拉万星原料中有关物质的检测方法
CN109078001B (zh) *	2018-09-21	2021-05-07	深圳浦瑞健康科技有限公司	一种万古霉素纳米脂质体组合物及其制备方法
CA3132923A1 (en)	2019-03-08	2020-09-17	Emphascience, Inc.	Stable pharmaceutical formulations of peptide and protein drugs
US20220133844A1 (en) *	2020-10-30	2022-05-05	Somerset Therapeutics, Llc	Glycopeptide antibiotics liquid formulations and methods and uses thereof
EP4014965A1 (en) *	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution
EP4014969A1 (en) *	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution
WO2022234036A1 (en) *	2021-05-07	2022-11-10	Xellia Pharmaceuticals Aps	Oral liquid vancomycin formulations
CN115804832A (zh) *	2021-09-14	2023-03-17	海南普利制药股份有限公司	一种万古霉素水溶液组合物
JPWO2023171588A1 (da) *	2022-03-08	2023-09-14
GB202207344D0 (en)	2022-05-19	2022-07-06	Arecor Ltd	Novel composition
GB202207345D0 (en)	2022-05-19	2022-07-06	Arecor Ltd	Novel composition
WO2024079224A1 (en) *	2022-10-12	2024-04-18	Xellia Pharmaceuticals Aps	Liquid dalbavancin composition
WO2024079223A1 (en) *	2022-10-12	2024-04-18	Xellia Pharmaceuticals Aps	Liquid dalbavancin composition
WO2025006267A1 (en) *	2023-06-26	2025-01-02	Venn Biosciences Corporation	Peptide biomarkers for diagnosing primary sclerosing cholangitis or primary biliary cholangitis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4670258A (en)	1984-02-10	1987-06-02	Vanderbilt University	Storable prepackaged aqueous solutions of vancomycin
PE40996A1 (es)	1994-01-28	1996-10-14	Lilly Co Eli	Derivado de antibiotico de glucopeptido
CA2238872A1 (en)	1995-12-01	1997-06-05	Eli Lilly And Company	Stable vancomycin hydrochloride solutions
JPH1180021A (ja)	1997-09-02	1999-03-23	Kayaku:Kk	バンコマイシン注射剤
US6800608B2 (en)	2001-06-22	2004-10-05	Beckman Coulter, Inc.	Homogeneous assay of vancomycin using a stable particle-vancomycin conjugate, a novel rate enhancer, and a novel dose response modulator
US7022712B2 (en) *	2002-03-26	2006-04-04	Arizona Board Of Regents On Behalf Of The University Of Arizona	Solubilization of weak bases
GB0212622D0 (en) *	2002-05-31	2002-07-10	Natural Technologies Group Ltd	Bacterial transforming agent
CN1826129A (zh) *	2002-07-09	2006-08-30	尖端医疗有限公司	与异亮氨酸硼脯氨酸化合物相关的方法和组合物
US20040077601A1 (en)	2002-07-09	2004-04-22	Point Therapeutics, Inc.	Methods and compositions relating to isoleucine boroproline compounds
MXPA05005338A (es)	2002-11-18	2005-12-14	Vicuron Pharm Inc	Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
KR20090052893A (ko)	2005-02-14	2009-05-26	비너스 레머디스 리미티드	약제 내성균에 의한 감염 질환을 위한 비경구 병용 요법
CN1857716A (zh) *	2006-03-14	2006-11-08	浙江大学	注射用盐酸万古霉素及其制备方法
JP2008201778A (ja) *	2007-01-25	2008-09-04	Mochida Pharmaceut Co Ltd	バンコマイシン液状製剤
CN102026666B (zh) *	2007-12-11	2013-10-16	常山凯捷健生物药物研发（河北）有限公司	促胰岛素肽缀合物制剂
JP2011080021A (ja)	2009-10-09	2011-04-21	Bridgestone Corp	熱可塑性エラストマー組成物及びその成形体
JP6012716B2 (ja) *	2011-05-19	2016-10-25	サヴァラ，インク．	乾燥粉末バンコマイシン組成物および関連する方法
WO2014026052A1 (en)	2012-08-08	2014-02-13	Vanderbilt University	Composition with biofilm dispersal agents
AU2013352259B2 (en)	2012-11-29	2018-06-14	Insmed Incorporated	Stabilized vancomycin formulations
CN104043104B (zh)	2013-03-15	2018-07-10	浙江创新生物有限公司	含盐酸万古霉素的喷雾干粉及其工业化制备方法
US9616098B2 (en) *	2013-05-30	2017-04-11	Scidose, Llc	Formulations of vancomycin
EP3145527B1 (en) *	2014-03-14	2021-12-01	Azurity Pharmaceuticals, Inc.	Composition and method for vancomycin oral liquid
KR102763211B1 (ko) *	2014-11-06	2025-02-04	셀리아 파마슈티칼즈 에이피에스	글리코펩티드 조성물
MX2018013584A (es)	2016-05-09	2019-04-01	Xellia Pharmaceuticals Aps	Formulaciones de antibioticos glicopeptidicos estabilizados.
US20220133844A1 (en)	2020-10-30	2022-05-05	Somerset Therapeutics, Llc	Glycopeptide antibiotics liquid formulations and methods and uses thereof
EP4014965A1 (en)	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution
EP4014969A1 (en)	2020-12-16	2022-06-22	EVER Valinject GmbH	Aqueous solution

2015
- 2015-11-06 KR KR1020237020985A patent/KR102763211B1/ko active Active
- 2015-11-06 SI SI201531539T patent/SI3542812T1/sl unknown
- 2015-11-06 HU HUE15791287A patent/HUE049857T2/hu unknown
- 2015-11-06 WO PCT/EP2015/075918 patent/WO2016071495A1/en active Application Filing
- 2015-11-06 SI SI201531067T patent/SI3215173T1/sl unknown
- 2015-11-06 EP EP20215453.0A patent/EP3834837A1/en active Pending
- 2015-11-06 KR KR1020177015221A patent/KR102603756B1/ko active Active
- 2015-11-06 SG SG11201703568WA patent/SG11201703568WA/en unknown
- 2015-11-06 EP EP19174849.0A patent/EP3542812B1/en active Active
- 2015-11-06 CN CN201580060330.2A patent/CN107073072B/zh active Active
- 2015-11-06 US US15/524,653 patent/US10188697B2/en active Active
- 2015-11-06 CA CA2964524A patent/CA2964524A1/en active Pending
- 2015-11-06 DK DK19174849.0T patent/DK3542812T3/da active
- 2015-11-06 NZ NZ731955A patent/NZ731955A/en unknown
- 2015-11-06 PT PT191748490T patent/PT3542812T/pt unknown
- 2015-11-06 EP EP22203229.4A patent/EP4147710A1/en active Pending
- 2015-11-06 RS RS20200080A patent/RS59851B1/sr unknown
- 2015-11-06 DK DK15791287.4T patent/DK3215173T3/da active
- 2015-11-06 PL PL19174849T patent/PL3542812T3/pl unknown
- 2015-11-06 ES ES15791287T patent/ES2769849T3/es active Active
- 2015-11-06 RS RS20210108A patent/RS61418B1/sr unknown
- 2015-11-06 MX MX2017005749A patent/MX2017005749A/es unknown
- 2015-11-06 PL PL15791287T patent/PL3215173T3/pl unknown
- 2015-11-06 HU HUE19174849A patent/HUE053347T2/hu unknown
- 2015-11-06 EP EP15791287.4A patent/EP3215173B8/en not_active Revoked
- 2015-11-06 JP JP2017523438A patent/JP6797795B2/ja active Active
- 2015-11-06 BR BR112017009405-3A patent/BR112017009405B1/pt active IP Right Grant
- 2015-11-06 ES ES19174849T patent/ES2852550T3/es active Active
- 2015-11-06 EA EA201790997A patent/EA035368B1/ru unknown
- 2015-11-06 CR CR20170234A patent/CR20170234A/es unknown
- 2015-11-06 TN TN2017000182A patent/TN2017000182A1/en unknown
- 2015-11-06 PT PT157912874T patent/PT3215173T/pt unknown
- 2015-11-06 AU AU2015341763A patent/AU2015341763B2/en active Active
2017
- 2017-04-18 PH PH12017500720A patent/PH12017500720A1/en unknown
- 2017-04-19 ZA ZA2017/02767A patent/ZA201702767B/en unknown
- 2017-05-01 SA SA517381446A patent/SA517381446B1/ar unknown
- 2017-05-04 IL IL252120A patent/IL252120B/en active IP Right Grant
- 2017-05-05 CL CL2017001139A patent/CL2017001139A1/es unknown
- 2017-05-26 CO CONC2017/0005391A patent/CO2017005391A2/es unknown
- 2017-11-30 US US15/827,719 patent/US10039804B2/en active Active
2018
- 2018-12-11 US US16/216,446 patent/US10849956B2/en active Active
2019
- 2019-11-07 US US16/677,057 patent/US11000567B2/en active Active
2020
- 2020-01-21 HR HRP20200101TT patent/HRP20200101T1/hr unknown
- 2020-03-20 CY CY20201100266T patent/CY1122960T1/el unknown
- 2020-07-20 JP JP2020123671A patent/JP7032488B2/ja active Active
2021
- 2021-03-01 HR HRP20210342TT patent/HRP20210342T8/hr unknown
- 2021-03-29 US US17/215,675 patent/US11628200B2/en active Active
- 2021-04-09 CY CY20211100307T patent/CY1124011T1/el unknown
2022
- 2022-07-08 US US17/860,642 patent/US11517609B2/en active Active
2023
- 2023-01-06 US US18/151,155 patent/US12161690B2/en active Active

Also Published As

Publication number	Publication date
ZA201702767B (en)	2018-12-19
AU2015341763A1 (en)	2017-06-08
JP2020183424A (ja)	2020-11-12
HRP20200101T1 (hr)	2020-04-03
EP3215173B8 (en)	2020-03-11
KR102763211B1 (ko)	2025-02-04
BR112017009405B1 (pt)	2024-02-06
US20170348385A1 (en)	2017-12-07
PT3215173T (pt)	2020-04-03
EP3215173B1 (en)	2020-01-01
ES2852550T3 (es)	2021-09-13
CY1122960T1 (el)	2021-10-29
HUE053347T2 (hu)	2021-06-28
US11000567B2 (en)	2021-05-11
CY1124011T1 (el)	2022-05-27
CN107073072B (zh)	2021-06-18
KR20230096142A (ko)	2023-06-29
NZ731955A (en)	2023-07-28
KR102603756B1 (ko)	2023-11-16
EA035368B1 (ru)	2020-06-03
CR20170234A (es)	2018-01-15
US10188697B2 (en)	2019-01-29
US12161690B2 (en)	2024-12-10
CN107073072A (zh)	2017-08-18
MX2017005749A (es)	2018-01-11
CO2017005391A2 (es)	2017-10-31
EP3215173A1 (en)	2017-09-13
RS61418B1 (sr)	2021-03-31
US20200069768A1 (en)	2020-03-05
SI3542812T1 (sl)	2021-04-30
DK3542812T3 (da)	2021-04-12
HUE049857T2 (hu)	2020-10-28
EA201790997A1 (ru)	2017-09-29
US10849956B2 (en)	2020-12-01
PH12017500720A1 (en)	2017-10-09
US20210220433A1 (en)	2021-07-22
EP3834837A1 (en)	2021-06-16
IL252120B (en)	2020-07-30
IL252120A0 (en)	2017-07-31
SI3215173T1 (sl)	2020-03-31
US20190160142A1 (en)	2019-05-30
JP7032488B2 (ja)	2022-03-08
JP2017533218A (ja)	2017-11-09
US11517609B2 (en)	2022-12-06
BR112017009405A2 (pt)	2018-01-02
WO2016071495A1 (en)	2016-05-12
EP3542812B1 (en)	2021-01-13
PL3215173T3 (pl)	2020-05-18
PT3542812T (pt)	2021-04-20
AU2015341763B2 (en)	2019-01-17
ES2769849T3 (es)	2020-06-29
HRP20210342T1 (hr)	2021-04-30
TN2017000182A1 (en)	2018-10-19
CA2964524A1 (en)	2016-05-12
US11628200B2 (en)	2023-04-18
KR20170078830A (ko)	2017-07-07
SA517381446B1 (ar)	2020-09-21
EP4147710A1 (en)	2023-03-15
US10039804B2 (en)	2018-08-07
HRP20210342T8 (hr)	2022-01-21
US20230158101A1 (en)	2023-05-25
PL3542812T3 (pl)	2021-07-12
US20180133286A1 (en)	2018-05-17
SG11201703568WA (en)	2017-05-30
JP6797795B2 (ja)	2020-12-09
EP3542812A1 (en)	2019-09-25
US20220354927A1 (en)	2022-11-10
CL2017001139A1 (es)	2017-12-01
RS59851B1 (sr)	2020-02-28

Publication	Publication Date	Title
EP3534968A4 (en)	2020-07-01	ANTI-BCMA T CAR LYMPHOCYTE COMPOSITIONS
DK3361870T3 (da)	2020-05-11	Fungicidsammensætninger
DK3209778T3 (da)	2019-05-27	Kombination
DK3215173T3 (da)	2020-03-23	Glycopeptidsammensætninger
DK3040326T3 (da)	2020-03-30	Haloolefin-baseret sammensætning
DK3139769T3 (da)	2022-08-01	Næringsrige sammensætninger
EP3398996A4 (en)	2019-07-31	COMPOSITION
SMT202400518T1 (it)	2025-01-14	Composizioni anticancro
BR112017001922A2 (pt)	2018-07-17	composições fungicidas
DK3250182T3 (da)	2023-06-26	Dispergible sammensætninger
PL3034554T3 (pl)	2021-02-22	Kompozycje poliamidowe
DK3226842T3 (da)	2021-01-25	Anticancersammensætninger
PL3015500T3 (pl)	2019-09-30	Kompozycje poliamidowe
DK3334726T3 (da)	2022-05-16	Plinabulinsammensætninger
FR3024363B1 (fr)	2018-08-10	Composition thermogelifiable
DK3226843T3 (da)	2021-08-16	Anticancersammensætninger
PL2924070T3 (pl)	2017-10-31	Kompozycje poliamidów
DK3129007T3 (da)	2020-11-02	Vaccinesammensætninger
CL2017000639A1 (es)	2018-01-26	Composición
EP3395887C0 (en)	2024-08-28	Fluororubber composition
DK3393254T3 (da)	2021-07-26	Sammensætning
EP3369418A4 (en)	2019-07-31	COMPOSITION
DK3316857T3 (da)	2021-10-18	Multifasiske sammensætninger
DK3528791T3 (da)	2024-01-29	Dispergible sammensætninger
DK3322295T3 (da)	2022-12-19	Sammensætning